Cimetidine prevents suppression of delayed hypersensitivity in an animal model of haemorrhagic shock

Injury

Volumn 33, Issue 8, 2002, Pages 673-678

  Hewitt, Peter MacD ^a   Armstrong, Neil ^a   Bowrey, Patricia ^a   Cherian, Maya ^a   Morris, David Lawson ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; FOOT PAD; HEART; HEMORRHAGIC SHOCK; HISTOPATHOLOGY; IMMUNOMODULATION; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; PUNCTURE; RANDOMIZATION; SENSITIZATION; SHEEP ERYTHROCYTE; THICKNESS;

ADMINISTRATION, ORAL; ANIMALS; CHI-SQUARE DISTRIBUTION; CIMETIDINE; ERYTHROCYTE TRANSFUSION; HISTAMINE H2 ANTAGONISTS; HYPERSENSITIVITY, DELAYED; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; SHEEP; SHOCK, HEMORRHAGIC;

EID: 0036789276     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-1383(02)00095-5     Document Type: Article

References (37)

1. Ayala A., Lehman D.L., Herdon C.D., Chaudry I.H. Mechanism of enhanced susceptibility to sepsis following haemorrhage. Arch. Surg. 129:1994;1172-1178.
2. Hansbrough J., Peterson V., Zapata-Sirvent R.L., Claman H.N. Postburn immunosuppression in an animal model. II. Restoration of cell-mediated immunity by immunomodulating drugs. Surgery. 95:1984;290-295.
3. Miller S.E., Miller C.L., Trunkey D.D. The immune consequences of trauma. Surg. Clin. North Am. 62:1982;167-181.
4. Baker C.C., Oppenheimer L., Stephens B., Lewis F.R., Trunkey D.D. Epidemiology of trauma deaths. Am. J. Surg. 140:1980;144-150.
5. Esrig B.C., Frazee L., Stephenson S.F., Fulton R.L., Jones C.E. Predisposition to infection and neutrophil function following haemorrhagic shock. Rev. Surg. 33:1976;431-433.
6. Stephan R.N., Kupper T.S., Geha A.S., Baue A.E., Chaudry I.H. Haemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch. Surg. 122:1987;62-68.
7. Chang Y.H., Jagels M., Abraham E. Haemorrhage produces depressions in alloantigen-specific immune responses in the mouse through activation of suppressor T cells. Clin. Exp. Immunol. 80:1990;478-483.
8. Abraham E., Freitas A.A. Haemorrhage produces abnormalities in lymphocyte function and lymphokine generation. J. Immunol. 142:1989;899-906.
9. Livingston D.H. Interferon-γ reverses bone marrow inhibition following haemorrhagic shock. Arch. Surg. 126:1991;100-103.
10. Nielsen H.J., Nielsen H., Jensen S., Moesgaard F. Ranitidine improves postoperative monocyte and neutrophil function. Arch. Surg. 129:1994;309-315.
11. Sedman P.C., Ramsden C.W., Brenan T.G.et al. Effects of low dose perioperative interferon on the surgically induced suppression of antitumor immune responses. Br. J. Surg. 75:1988;976-981.
12. Nielsen H.J., Witt K., Moesgaard F., Kehlet H. Ranitidine for prevention of postoperative suppression of delayed hypersensitivity. Am. J. Surg. 157:1989;291-294.
13. Nielsen H.J., Witt K., Moesgaard F., Kehlet H. Ranitidine for improvement of delayed hypersensitivity response in patients with sepsis. Acta Chir. Scand. 155:1989;445-449.
14. Nielsen H.J., Hammer J.H., Moesgaard F., Kehlet H. Ranitidine prevents postoperative transfusion-induced depression of delayed hypersensitivity. Surgery. 105:1989;711-717.
15. Leeper-Woodford S.K., Carey D., Byrne K.et al. Histamine receptor antagonists, cyclooxygenase blockade, and tumor necrosis factor during acute septic insult. Shock. 9:1998;89-94.
16. Lennard T.W.J., Shenton B.K., Borzotta A.et al. The influence of surgical operations on components of the human immune system. Br. J. Surg. 72:1985;771-776.
17. Baigrie R.J., Lamont P.M., Kwiatkowski D., Dallman M.J., Morris P.J. Systemic cytokine response after major surgery. Br. J. Surg. 79:1992;757-760.
18. Christou N.V., Meakins J.L., Gordon J.et al. The delayed hypersensitivity response and host resistance in surgical patients. Ann. Surg. 222:1995;534-548.
19. Hall J.M., Hallett C. A simple precise method for measuring rodent paw volume. J. Pharm. Pharmacol. 27:1975;623.
20. Johnson K.B., Charya R.V., Atkins J.L., Wiesmann W.P., Pearce F.J. The role of histamine in mediating the decompensatory phase of haemorrhagic shock in the rat. Shock. 8:1997;444-449.
21. Griswold D.E., Alessi S., Badger A.M., Poste G., Hanna N. Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists. J. Immunol. 132:1984;3054-3057.
22. Birch R.E., Polmar S.H. Pharmacological modification of immunoregulatory T lymphocytes. I. Effect of adenosine. Clin. Exp. Immunol. 48:1982;218-230.
23. Rocklin R.E. Histamine-induced suppressor factor (HSF): effect on migration inhibitory factor (MIF) production and proliferation. J. Immunol. 118:1977;1734-1738.
24. Rezai A.R., Salazar-Gonzalez J.F., Martinez-Maza O., Bramhall J., Afrasiabi R., Kermani-Arab V. Histamine blocks interleukin 2 (IL2) gene expression and regulates IL2 receptor expression. Immunopharmacol. Immunotoxicol. 12:1990;345-362.
25. Schnaper H.W., Aune T.M., Roby R.K. A role for histamine type II (H-2) receptor binding in production of the lymphokine, soluble immune response suppressor (SIRS). J. Immunol. 139:1987;1185-1190.
26. Suzuki S., Huchet R. Properties of histamine-induced suppressor factor in the regulation of lymphocyte response to PHA in mice. Cell Immunol. 68:1982;349-358.
27. Rocklin R.E., Blidy A., Kamal M. Physiochemical characterization of human histamine-induced suppressor factor. Cell Immunol. 76:1983;243-252.
28. Dohlsten M., Sjogren H.O., Carlson R. Histamine inhibits interferon-γ production via suppression of interleukin-2 synthesis. Cell Immunol. 39:1986;493-501.
29. Gifford R.R., Tilberg A.F. Histamine type-2 receptor antagonist immune modulation. II. Cimetidine and ranitidine increase interleukin-2 production. Surgery. 102:1987;242-247.
30. Hansbrough J.F., Zapata-Sirvent R.L., Bender E.M. Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofen. Am. J. Surg. 151:1986;249-255.
31. Zapata-Sirvent R.L., Hansbrough J.F. Postburn immunosuppression in an animal model. III. Maintenance of normal splenic helper and suppressor lymphocyte subpopulations by immunomodulating drugs. Surgery. 97:1985;721-727.
32. Adams W.J., Lawson J.A., Morris D.L. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut. 35:1994;1632-1636.
33. Kelly M.D., King J., Cherian M.et al. Randomized trial of preoperative cimetidine in patients with colorectal carcinoma with quantitative assessment of tumor-associated lymphocytes. Cancer. 85:1999;1658-1663.
34. Adams W.J., Morris D.L. Pilot study - cimetidine enhances lymphocyte infiltration of human colorectal carcinoma. Cancer. 80:1997;15-21.
35. Zapata-Sirvent R.L., Hansbrough J.F., Bender E.M., Bartle E.J., Mansour A., Carter W.H. Postburn immunosuppression in an animal model. IV. Improved resistance to septic challenge with immunomodulating drugs. Surgery. 99:1986;53-59.
36. Stewart R.M., Fabian T.C., Fabian M.J.et al. Gastric and extragastric actions of the histamine antagonist ranitidine during posttraumatic sepsis. Surgery. 117:1995;68-82.
37. Vial T., Goubier C., Bergeret A., Cabrera F., Evreaux J.C., Descotes J. Side effects of ranitidine. Drug Saf. 6:1991;94-117.